IDSA and HIVMA guide legislation responding to opioid ID impacts

As key Committees in Congress turned their attention to the opioid crisis, IDSA and HIVMA ensured their legislation addressed the intersection of infectious diseases and substance use disorders, as well as the need to build ID and HIV provider capacity into the response.

The Senate Health, Education, Labor and Pensions Committee modified its Opioid Crisis Response Act in response to IDSA/HIVMA recommendations to include infective endocarditis in addition to viral hepatitis and HIV in new surveillance activities and to include clinicians caring for patients with infectious diseases related to substance use in new loan repayment opportunities through the National Health Service Corps. Because of our advocacy, the bill also now authorizes infectious diseases testing through comprehensive opioid recovery centers that would be created under the bill. The HELP Committee approved this important legislation on April 24, and the full Senate is expected to consider it this summer. Read More.

May 15 webinar to offer advocacy tips
IDSA, HIVMA, and PIDS have scheduled an advocacy webinar on ways to engage policymakers at home and in Washington, DC-and you're invited. In addition to practical tips on building relationships with elected officials as well as their staff members, and conducting productive meetings, IDSA and HIVMA member advocates will share their experiences with members of Congress, discuss the ways that advocacy can make a difference, and take questions. Read More.

Educate policymakers on 340B and ID/HIV

In January 2018, the Centers for Medicare and Medicaid Services reduced 340B reimbursement for Medicare Part B drugs to some participating hospitals, potentially cutting support for services provided to uninsured and underinsured patients at these facilities. In addition, Congressional members have indicated an interest in making changes to the program with similar bills being introduced in the House and Senate that would put a moratorium on new participating hospital sites and impose new data reporting requirements. Read More.

IDSA & HIVMA weigh in as House begins work on FY 2019 federal funding bills 

As lawmakers confront a White House budget plan proposing deep cuts to research, public health and global health programs, and consider their priorities for the year to come, IDSA and HIVMA leaders are weighing in. 

HIVMA board member Dr. Marwan Haddad testified April 26 at the House Appropriations Labor, Health and Human Services, and Education subcommittee public witness hearing on the need to increase funding for Ryan White Part C clinics and to leverage Ryan White clinics in responding to national opioid epidemic. His testimony can be found onlineRead More.